Incyte Biosciences Distribution B.V.
1 recorded win · — total awarded value (where disclosed).
Records136,978 tendersNewest notice2026-06-24Last ingest2026-06-25 · TED daily 06:00Parser health (7d)all runs clean
| Published | Title | Buyer | Awarded |
|---|---|---|---|
| 2026-06-22 | Ex-Ante-Transparenzbekanntmachung § 130c Abs. 1 SGB V Arzneimittelbezeichnung Opzelura (R) Wirkstoff: Ruxolitinib ATC-Code: D11AH09 | AOK Bayern - Die Gesundheitskasse DE | — |